If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
559.00    3.00 (0.54%)
Bid:
556.50
Ask:
557.00
Spread: 0.50 (0.09%)
Market Cap: £2.47b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Director/PDMR Shareholding

5 Apr 2018 16:31

Tate & Lyle PLC

Notification of transactions by Persons Discharging Managerial Responsibilities

Tate & Lyle PLC (the ‘Company’) announces that it was informed yesterday that transactions occurred by Persons Discharging Managerial Responsibilities (‘PDMR’) in respect of their interests in ordinary shares of 25 pence each in the capital of the Company (‘Shares’) under the 2016 Conditional Share Award programme (‘CSA’).

No consideration was paid for the acquisition of these Shares. Awards made under the CSA were subject to certain Company-based financial performance criteria satisfied over a performance period which ran from 1 April 2016 to 31 March 2017. The Awards were further subject to a 12-month deferral period and continued employment to 31 March 2018.

Following the withholding of Shares to satisfy certain tax obligations arising on the exercise of nil-cost options or the release of Shares, the PDMR’s interests in Shares changed as detailed in the table below:

PDMR   Date of Transaction   No. of Shares acquired under the CSA
Rowan Adams 4 April 2018 25,144
Joan Braca 3 April 2018 37,814
Jim Stutelberg 3 April 2018 25,170

For tax purposes, the market value of the Shares, being the average of the two close prices on the date of the transaction, was 542.4 pence per Share on 4 April 2018 and 537.6 pence per Share on 3 April 2018.

The notifications below, which have been made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.

Claire-Marie O’Grady Company Secretary 5 April 2018

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

    Details of PDMR / person closely associated with them (“PCA”)
a) Name   Rowan Adams
2. Reason for the notification
a) Position / status PDMR – Executive Vice President, Corporate Affairs
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

 

GB0008754136

b) Nature of the transaction Acquisition of shares following the exercise of nil-cost options over shares for no consideration.
c) Price(s) and volume(s)

Price(s) Nil

 

 

Volume(s) 25,144

d) Aggregated information

 

Aggregated volume Price

25,144 Nil

 

e) Date of the transaction 2017-04-04
f) Place of the transaction Outside a trading venue

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

    Details of PDMR / person closely associated with them (“PCA”)
a) Name   Joan Braca
2. Reason for the notification
a) Position / status PDMR – President, Speciality Food Ingredients
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

 

GB0008754136

b) Nature of the transaction Acquisition of shares following the release of nil-cost conditional awards over shares for no consideration.
c) Price(s) and volume(s)

Price(s) Nil

 

 

Volume(s) 37,814

d) Aggregated information

 

Aggregated volume Price

37,814 Nil

e) Date of the transaction 2017-04-03
f) Place of the transaction Outside a trading venue

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

    Details of PDMR / person closely associated with them (“PCA”)
a) Name   Jim Stutelberg
2. Reason for the notification
a) Position / status PDMR – President, Global Operations
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

 

GB0008754136

b) Nature of the transaction Acquisition of shares following the release of nil-cost conditional awards over shares for no consideration.
c) Price(s) and volume(s)

Price(s) Nil

 

 

Volume(s) 25,170

d) Aggregated information

 

Aggregated volume Price

25,170 Nil

e) Date of the transaction 2017-04-03
f) Place of the transaction Outside a trading venue

View source version on businesswire.com: https://www.businesswire.com/news/home/20180405005843/en/

Copyright Business Wire 2018

Date   Source Headline
4th Sep 20245:58 pmRNSTransaction in Own Shares
3rd Sep 20245:33 pmRNSTransaction in Own Shares
2nd Sep 20245:44 pmRNSTransaction in Own Shares
2nd Sep 20245:00 pmRNSTotal Voting Rights
30th Aug 20245:39 pmRNSTransaction in Own Shares
29th Aug 20245:26 pmRNSTransaction in Own Shares
28th Aug 20245:27 pmRNSTransaction in Own Shares
27th Aug 20245:34 pmRNSTransaction in Own Shares
23rd Aug 20245:49 pmRNSTransaction in Own Shares
22nd Aug 20245:45 pmRNSTransaction in Own Shares
22nd Aug 20244:00 pmRNSDirector/PDMR Shareholding
21st Aug 20246:00 pmRNSTransaction in Own Shares
20th Aug 20245:56 pmRNSTransaction in Own Shares
19th Aug 20245:44 pmRNSTransaction in Own Shares
16th Aug 20245:50 pmRNSTransaction in Own Shares
15th Aug 20245:57 pmRNSTransaction in Own Shares
14th Aug 20245:46 pmRNSTransaction in Own Shares
13th Aug 20245:54 pmRNSTransaction in Own Shares
13th Aug 20247:00 amRNSDirectorate Change
12th Aug 20245:43 pmRNSTransaction in Own Shares
9th Aug 20245:23 pmRNSTransaction in Own Shares
8th Aug 20245:50 pmRNSTransaction in Own Shares
8th Aug 20244:00 pmRNSDirector/PDMR Shareholding
7th Aug 20245:34 pmRNSTransaction in Own Shares
7th Aug 20244:05 pmRNSNotification of transactions by PDMRs
6th Aug 20245:29 pmRNSTransaction in Own Shares
5th Aug 20245:35 pmRNSTransaction in Own Shares
2nd Aug 20245:46 pmRNSTransaction in Own Shares
1st Aug 20245:28 pmRNSTransaction in Own Shares
1st Aug 20242:30 pmRNSTotal Voting Rights
31st Jul 20245:15 pmRNSTransaction in Own Shares
30th Jul 20245:23 pmRNSTransaction in Own Shares
29th Jul 20245:34 pmRNSTransaction in Own Shares
29th Jul 20242:00 pmRNSCompany Secretary Change
26th Jul 20245:33 pmRNSTransaction in Own Shares
25th Jul 20245:28 pmRNSTransaction in Own Shares
25th Jul 20242:00 pmRNSResult of AGM
25th Jul 20247:00 amRNSTrading Statement
24th Jul 20245:24 pmRNSTransaction in Own Shares
24th Jul 20245:15 pmRNSTotal Voting Rights
23rd Jul 20245:40 pmRNSTransaction in Own Shares
22nd Jul 20245:26 pmRNSTransaction in Own Shares
19th Jul 20245:33 pmRNSTransaction in Own Shares
18th Jul 20245:37 pmRNSTransaction in Own Shares
18th Jul 202410:00 amRNSDirector/PDMR Shareholding
17th Jul 20245:45 pmRNSTransaction in Own Shares
16th Jul 20245:25 pmRNSTransaction in Own Shares
15th Jul 20245:20 pmRNSTransaction in Own Shares
15th Jul 202411:00 amRNSHolding(s) in Company
12th Jul 20245:55 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.